Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Autoimmune Disorders

  Free Subscription


Articles published in J Autoimmun

Retrieve available abstracts of 124 articles:
HTML format



Single Articles


    June 2022
  1. BAKASIS AD, Mavragani CP, Voulgari PV, Gerolymatou N, et al
    COVID-19: Clinical features and outcomes in unvaccinated 2-dose and 3-dose vaccinated against SARS-CoV-2 patients with systemic autoimmune and autoinflammatory rheumatic diseases.
    J Autoimmun. 2022;131:102846.
    PubMed     Abstract available


  2. HUANG C, Yi P, Zhu M, Zhou W, et al
    Safety and efficacy of fecal microbiota transplantation for treatment of systemic lupus erythematosus: An EXPLORER trial.
    J Autoimmun. 2022 Jun 8:102844. doi: 10.1016/j.jaut.2022.102844.
    PubMed     Abstract available


  3. WANG C, Zhou W, Liu Y, Xu Y, et al
    Nuclear translocation of RIG-I promotes cellular apoptosis.
    J Autoimmun. 2022;130:102840.
    PubMed     Abstract available


    May 2022
  4. BUCCI T, Ames PR, Cammisotto V, Bartimoccia S, et al
    Proprotein convertase subtilisin/kexin type 9 (PCSK9) levels in primary antiphospholipid syndrome. The multicenter ATHERO-APS study.
    J Autoimmun. 2022;129:102832.
    PubMed     Abstract available


  5. FAN NW, Wang S, Ortiz G, Chauhan SK, et al
    Autoreactive memory Th17 cells are principally derived from T-bet(+)RORgammat(+) Th17/1 effectors.
    J Autoimmun. 2022;129:102816.
    PubMed     Abstract available


    April 2022
  6. MELDERIS S, Warkotsch MT, Dang J, Hagenstein J, et al
    The Amphiregulin/EGFR axis protects from lupus nephritis via downregulation of pathogenic CD4(+) T helper cell responses.
    J Autoimmun. 2022;129:102829.
    PubMed     Abstract available


  7. COUTANT F, Bachet R, Pin JJ, Alonzo M, et al
    Monoclonal antibodies from B cells of patients with anti-MDA5 antibody-positive dermatomyositis directly stimulate interferon gamma production.
    J Autoimmun. 2022;130:102831.
    PubMed     Abstract available


  8. LI X, Gao L, Tong X, Chan VKY, et al
    Autoimmune conditions following mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccination: A descriptive cohort study among 1.1 million vaccinated people in Hong Kong.
    J Autoimmun. 2022;130:102830.
    PubMed     Abstract available


    March 2022
  9. ZHAO Z, Zhu H, Li Q, Liao W, et al
    Skin CD4(+) Trm cells distinguish acute cutaneous lupus erythematosus from localized discoid lupus erythematosus/subacute cutaneous lupus erythematosus and other skin diseases.
    J Autoimmun. 2022;128:102811.
    PubMed     Abstract available


  10. CENTA M, Weinstein EG, Clemente JC, Faith JJ, et al
    Impaired central tolerance induces changes in the gut microbiota that exacerbate autoimmune hepatitis.
    J Autoimmun. 2022;128:102808.
    PubMed     Abstract available


  11. TEKTONIDOU MG
    Cardiovascular disease risk in antiphospholipid syndrome: Thrombo-inflammation and atherothrombosis.
    J Autoimmun. 2022;128:102813.
    PubMed     Abstract available


    February 2022
  12. BOSTAN H, Ucan B, Kizilgul M, Calapkulu M, et al
    Relapsed and newly diagnosed Graves' disease due to immunization against COVID-19: A case series and review of the literature.
    J Autoimmun. 2022;128:102809.
    PubMed     Abstract available


  13. TIAN J, Zhou H, Fang D, Yi P, et al
    The global burden of heterogeneity of lupus erythematosus interventional trials.
    J Autoimmun. 2022;128:102798.
    PubMed     Abstract available


  14. OHTO T, Tayeh AA, Nishikomori R, Abe H, et al
    Intracellular virus sensor MDA5 mutation develops autoimmune myocarditis and nephritis.
    J Autoimmun. 2022;127:102794.
    PubMed     Abstract available


  15. ARASE N, Tsuji H, Takamatsu H, Jin H, et al
    Corrigendum to "Cell surface-expressed Ro52/IgG/HLA-DR complex is targeted by autoantibodies in patients with inflammatory myopathies" [J. Autoimmun. 126 (2022) 102774].
    J Autoimmun. 2022 Feb 9:102797. doi: 10.1016/j.jaut.2022.102797.
    PubMed    


  16. VIEIRA M, Regnier P, Maciejewski-Duval A, Le Joncour A, et al
    Interferon signature in giant cell arteritis aortitis.
    J Autoimmun. 2022;127:102796.
    PubMed     Abstract available


    January 2022
  17. HANSEN CHF, Larsen CS, Zachariassen LF, Mentzel CMJ, et al
    Gluten-free diet reduces autoimmune diabetes mellitus in mice across multiple generations in a microbiota-independent manner.
    J Autoimmun. 2022;127:102795.
    PubMed     Abstract available


  18. PASSAM FH, Chen G, Chen VM, Qi M, et al
    Betaeta-2-glycoprotein I exerts antithrombotic function through its domain V in mice.
    J Autoimmun. 2022;126:102747.
    PubMed     Abstract available


    December 2021
  19. AFRASIABI A, Keane JT, Ong LTC, Alinejad-Rokny H, et al
    Genetic and transcriptomic analyses support a switch to lytic phase in Epstein Barr virus infection as an important driver in developing Systemic Lupus Erythematosus.
    J Autoimmun. 2021;127:102781.
    PubMed     Abstract available


  20. ROJAS M, Ramirez-Santana C, Acosta-Ampudia Y, Monsalve DM, et al
    New insights into the taxonomy of autoimmune diseases based on polyautoimmunity.
    J Autoimmun. 2021;126:102780.
    PubMed     Abstract available


  21. ARASE N, Tsuji H, Takamatsu H, Jin H, et al
    Cell surface-expressed Ro52/IgG/HLA-DR complex is targeted by autoantibodies in patients with inflammatory myopathies.
    J Autoimmun. 2021;126:102774.
    PubMed     Abstract available


  22. MAHROUM N, Alghory A, Kiyak Z, Alwani A, et al
    Ferritin - from iron, through inflammation and autoimmunity, to COVID-19.
    J Autoimmun. 2021;126:102778.
    PubMed     Abstract available


  23. RAIKER R, Pakhchanian H, DeYoung C, Gupta L, et al
    Short term outcomes of COVID-19 in lupus: Propensity score matched analysis from a nationwide multi-centric research network.
    J Autoimmun. 2021;125:102730.
    PubMed     Abstract available


    November 2021
  24. AVCI E, Abasiyanik F
    Autoimmune hepatitis after SARS-CoV-2 vaccine: New-onset or flare-up?
    J Autoimmun. 2021;125:102745.
    PubMed     Abstract available


  25. FERRI C, Ursini F, Gragnani L, Raimondo V, et al
    Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups.
    J Autoimmun. 2021;125:102744.
    PubMed     Abstract available


  26. PADOAN R, Gatto M, Ghirardello A, Tonello M, et al
    IgG anti-Pentraxin 3 antibodies are a novel biomarker of ANCA-associated vasculitis and better identify patients with eosinophilic granulomatosis with polyangiitis.
    J Autoimmun. 2021;124:102725.
    PubMed     Abstract available


    October 2021
  27. TZIOUFAS AG, Bakasis AD, Goules AV, Bitzogli K, et al
    A prospective multicenter study assessing humoral immunogenicity and safety of the mRNA SARS-CoV-2 vaccines in Greek patients with systemic autoimmune and autoinflammatory rheumatic diseases.
    J Autoimmun. 2021;125:102743.
    PubMed     Abstract available


  28. HANSEN N, Krasiuk I, Titsch T
    Neural autoantibodies in delirium.
    J Autoimmun. 2021;125:102740.
    PubMed     Abstract available


  29. GARRIDO I, Lopes S, Simoes MS, Liberal R, et al
    Autoimmune hepatitis after COVID-19 vaccine - more than a coincidence.
    J Autoimmun. 2021;125:102741.
    PubMed     Abstract available


  30. PATRIZIO A, Ferrari SM, Antonelli A, Fallahi P, et al
    A case of Graves' disease and type 1 diabetes mellitus following SARS-CoV-2 vaccination.
    J Autoimmun. 2021;125:102738.
    PubMed     Abstract available


    September 2021
  31. GATTO M, Saccon F, Andreoli L, Bartoloni E, et al
    Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort.
    J Autoimmun. 2021;124:102729.
    PubMed     Abstract available


  32. RELA M, Jothimani D, Vij M, Rajakumar A, et al
    Auto-immune hepatitis following COVID vaccination.
    J Autoimmun. 2021;123:102688.
    PubMed     Abstract available


  33. BOGIE JFJ, Vanmierlo T, Vanmol J, Timmermans S, et al
    Liver X receptor beta deficiency attenuates autoimmune-associated neuroinflammation in a T cell-dependent manner.
    J Autoimmun. 2021;124:102723.
    PubMed     Abstract available


  34. SALVIANO-SILVA A, Becker M, Augusto DG, Busch H, et al
    Genetic association and differential expression of HLAComplexGroup lncRNAs in pemphigus.
    J Autoimmun. 2021;123:102705.
    PubMed     Abstract available


  35. VALENTINE KM, Mullins GN, Davalos OA, Seow LW, et al
    CD8 follicular T cells localize throughout the follicle during germinal center reactions and maintain cytolytic and helper properties.
    J Autoimmun. 2021;123:102690.
    PubMed     Abstract available


    August 2021
  36. LEE AYS, Reed JH, Gordon TP
    Anti-Ro60 and anti-Ro52/TRIM21: Two distinct autoantibodies in systemic autoimmune diseases.
    J Autoimmun. 2021;124:102724.
    PubMed     Abstract available


  37. HIRSIGER JR, Tamborrini G, Harder D, Bantug GR, et al
    Chronic inflammation and extracellular matrix-specific autoimmunity following inadvertent periarticular influenza vaccination.
    J Autoimmun. 2021;124:102714.
    PubMed     Abstract available


  38. HEMED-SHAKED M, Cowman MK, Kim JR, Huang X, et al
    MTADV 5-MER peptide suppresses chronic inflammations as well as autoimmune pathologies and unveils a new potential target-Serum Amyloid A.
    J Autoimmun. 2021;124:102713.
    PubMed     Abstract available


  39. HANSEN RB, Simard JF, Faurschou M, Jacobsen S, et al
    Distinct patterns of comorbidity prior to diagnosis of incident systemic lupus erythematosus in the Danish population.
    J Autoimmun. 2021;123:102692.
    PubMed     Abstract available


  40. LU Q, Long H, Chow S, Hidayat S, et al
    Guideline for the diagnosis, treatment and long-term management of cutaneous lupus erythematosus.
    J Autoimmun. 2021;123:102707.
    PubMed     Abstract available


  41. RAJENDRAN S, Quesada-Masachs E, Zilberman S, Graef M, et al
    IL-17 is expressed on beta and alpha cells of donors with type 1 and type 2 diabetes.
    J Autoimmun. 2021;123:102708.
    PubMed     Abstract available


  42. ZHANG P, Zhang Y, Pan M, Liu Z, et al
    Proteomic analyses of plasma-derived exosomes in immunoglobulin (Ig) G4-related disease and their potential roles in B cell differentiation and tissue damage.
    J Autoimmun. 2021;122:102650.
    PubMed     Abstract available


    July 2021
  43. VUILLE-LESSARD E, Montani M, Bosch J, Semmo N, et al
    Autoimmune hepatitis triggered by SARS-CoV-2 vaccination.
    J Autoimmun. 2021;123:102710.
    PubMed     Abstract available


  44. ZHOU S, Li Q, Zhou S, Zhao M, et al
    A novel humanized cutaneous lupus erythematosus mouse model mediated by IL-21-induced age-associated B cells.
    J Autoimmun. 2021;123:102686.
    PubMed     Abstract available


  45. IBANEZ-VEGA J, Vilchez C, Jimenez K, Guevara C, et al
    Cellular and molecular regulation of the programmed death-1/programmed death ligand system and its role in multiple sclerosis and other autoimmune diseases.
    J Autoimmun. 2021;123:102702.
    PubMed     Abstract available


  46. BAKASIS AD, Mavragani CP, Boki KA, Tzioufas AG, et al
    COVID-19 infection among autoimmune rheumatic disease patients: Data from an observational study and literature review.
    J Autoimmun. 2021;123:102687.
    PubMed     Abstract available


  47. GHIELMETTI M, Schaufelberger HD, Mieli-Vergani G, Cerny A, et al
    Acute autoimmune-like hepatitis with atypical anti-mitochondrial antibody after mRNA COVID-19 vaccination: A novel clinical entity?
    J Autoimmun. 2021;123:102706.
    PubMed     Abstract available


  48. GRAVER JC, Abdulahad W, van der Geest KSM, Heeringa P, et al
    Association of the CXCL9-CXCR3 and CXCL13-CXCR5 axes with B-cell trafficking in giant cell arteritis and polymyalgia rheumatica.
    J Autoimmun. 2021;123:102684.
    PubMed     Abstract available


  49. REN HM, Lukacher AE, Rahman ZSM, Olsen NJ, et al
    New developments implicating IL-21 in autoimmune disease.
    J Autoimmun. 2021;122:102689.
    PubMed     Abstract available


  50. MCEACHERN E, Carroll AM, Fribourg M, Schiano TD, et al
    Corrigendum to "Erythropoietin administration expands regulatory T cells in patients with autoimmune hepatitis" [J. Autoimmun. 119C (2021) 102629].
    J Autoimmun. 2021;121:102665.
    PubMed    


  51. MCGONAGLE D, De Marco G, Bridgewood C
    Mechanisms of Immunothrombosis in Vaccine-Induced Thrombotic Thrombocytopenia (VITT) Compared to Natural SARS-CoV-2 Infection.
    J Autoimmun. 2021;121:102662.
    PubMed     Abstract available


  52. DOTAN A, Shoenfeld Y
    Perspectives on vaccine induced thrombotic thrombocytopenia.
    J Autoimmun. 2021;121:102663.
    PubMed     Abstract available


    June 2021
  53. MONSTED MO, Falck ND, Pedersen K, Buschard K, et al
    Intestinal permeability in type 1 diabetes: An updated comprehensive overview.
    J Autoimmun. 2021;122:102674.
    PubMed     Abstract available


  54. LINGEL H, Meltendorf S, Billing U, Thurm C, et al
    Unique autoantibody prevalence in long-term recovered SARS-CoV-2-infected individuals.
    J Autoimmun. 2021;122:102682.
    PubMed     Abstract available


  55. DIANA T, Ungerer M, Wuster C, Fassbender J, et al
    A cyclic peptide significantly improves thyroid function, thyrotropin-receptor antibodies and orbital mucine /collagen content in a long-term Graves' disease mouse model.
    J Autoimmun. 2021;122:102666.
    PubMed     Abstract available


  56. GU Y, Merriman C, Guo Z, Jia X, et al
    Novel autoantibodies to the beta-cell surface epitopes of ZnT8 in patients progressing to type-1 diabetes.
    J Autoimmun. 2021;122:102677.
    PubMed     Abstract available


  57. RODRIGUEZ-PEREZ AI, Labandeira CM, Pedrosa MA, Valenzuela R, et al
    Autoantibodies against ACE2 and angiotensin type-1 receptors increase severity of COVID-19.
    J Autoimmun. 2021;122:102683.
    PubMed     Abstract available


  58. KRILIS M, Qi M, Ioannou Y, Zhang JY, et al
    Clinical relevance of nitrated beta 2-glycoprotein I in antiphospholipid syndrome: Implications for thrombosis risk.
    J Autoimmun. 2021;122:102675.
    PubMed     Abstract available


  59. KJELDSEN J, Nielsen J, Ellingsen T, Knudsen T, et al
    Outcome of COVID-19 in hospitalized patients with chronic inflammatory diseases. A population based national register study in Denmark.
    J Autoimmun. 2021;120:102632.
    PubMed     Abstract available


  60. DE BRUYN CARLIER T, Badloe FMS, Ring J, Gutermuth J, et al
    Autoreactive T cells and their role in atopic dermatitis.
    J Autoimmun. 2021;120:102634.
    PubMed     Abstract available


    May 2021
  61. NISHIMURA T, Okayasu T, Hosoi H, Kitahara T, et al
    Long-term (16-26 years) follow-up outcome of steroid therapy in refractory autoimmune sensorineural hearing loss.
    J Autoimmun. 2021;121:102664.
    PubMed     Abstract available


  62. TAKESHITA M, Suzuki K, Nakazawa M, Kamata H, et al
    Antigen-driven autoantibody production in lungs of interstitial lung disease with autoimmune disease.
    J Autoimmun. 2021;121:102661.
    PubMed     Abstract available


  63. GRAHAM JJ, Longhi MS, Heneghan MA
    T helper cell immunity in pregnancy and influence on autoimmune disease progression.
    J Autoimmun. 2021;121:102651.
    PubMed     Abstract available


  64. GHESQUIERE T, Ciudad M, Ramon A, Greigert H, et al
    Mucosal-associated invariant T cells in Giant Cell Arteritis.
    J Autoimmun. 2021;121:102652.
    PubMed     Abstract available


  65. KIM JS, Kim IH, Byun JM, Chang JH, et al
    Population-based study on the association between autoimmune disease and lymphoma: National Health Insurance Service-National Sample Cohort 2002-2015 in Korea.
    J Autoimmun. 2021;121:102647.
    PubMed     Abstract available


  66. YANAOKA H, Nagafuchi Y, Hanata N, Takeshima Y, et al
    Identifying the most influential gene expression profile in distinguishing ANCA-associated vasculitis from healthy controls.
    J Autoimmun. 2021;119:102617.
    PubMed     Abstract available


  67. HEIKKILA N, Sormunen S, Mattila J, Harkonen T, et al
    Generation of self-reactive, shared T-cell receptor alpha chains in the human thymus.
    J Autoimmun. 2021;119:102616.
    PubMed     Abstract available


  68. THANOU A, Jupe E, Purushothaman M, Niewold TB, et al
    Clinical disease activity and flare in SLE: Current concepts and novel biomarkers.
    J Autoimmun. 2021;119:102615.
    PubMed     Abstract available


  69. HAMMINGER P, Marchetti L, Preglej T, Platzer R, et al
    Histone deacetylase 1 controls CD4(+) T cell trafficking in autoinflammatory diseases.
    J Autoimmun. 2021;119:102610.
    PubMed     Abstract available


    April 2021
  70. VALENTI L, Griffini S, Lamorte G, Grovetti E, et al
    Corrigendum to "Chromosome 3 cluster rs11385942 variant links complement activation with severe COVID-19" [J. Autoimmun. 117C (2020) 102595].
    J Autoimmun. 2021;120:102646.
    PubMed    


  71. WILHELM M, Bonam SR, Schall N, Bendorius M, et al
    Implication of a lysosomal antigen in the pathogenesis of lupus erythematosus.
    J Autoimmun. 2021;120:102633.
    PubMed     Abstract available


  72. WANG JY, Zhang W, Roehrl MW, Roehrl VB, et al
    An autoantigen profile of human A549 lung cells reveals viral and host etiologic molecular attributes of autoimmunity in COVID-19.
    J Autoimmun. 2021;120:102644.
    PubMed     Abstract available


  73. VAN WIGCHEREN GF, Roelofs D, Figdor CG, Florez-Grau G, et al
    Three distinct tolerogenic CD14(+) myeloid cell types to actively manage autoimmune disease: Opportunities and challenges.
    J Autoimmun. 2021;120:102645.
    PubMed     Abstract available


    March 2021
  74. HALPERT G, Watad A, Tsur AM, Dotan A, et al
    Autoimmune dysautonomia in women with silicone breast implants.
    J Autoimmun. 2021;120:102631.
    PubMed     Abstract available


  75. MCEACHERN E, Carroll AM, Fribourg M, Schiano TD, et al
    Erythropoietin administration expands regulatory T cells in patients with autoimmune hepatitis.
    J Autoimmun. 2021;119:102629.
    PubMed     Abstract available


  76. BENKAHLA MA, Sabouri S, Kiosses WB, Rajendran S, et al
    HLA class I hyper-expression unmasks beta cells but not alpha cells to the immune system in pre-diabetes.
    J Autoimmun. 2021;119:102628.
    PubMed     Abstract available


    February 2021
  77. LONGHI MS, Mieli-Vergani G, Vergani D
    Regulatory T cells in autoimmune hepatitis: Un updated overview.
    J Autoimmun. 2021;119:102619.
    PubMed     Abstract available


  78. PALM AE, Kleinau S
    Marginal zone B cells: From housekeeping function to autoimmunity?
    J Autoimmun. 2021;119:102627.
    PubMed     Abstract available


  79. KHOSRAVI-MAHARLOOEI M, Li H, Hoelzl M, Zhao G, et al
    Role of the thymus in spontaneous development of a multi-organ autoimmune disease in human immune system mice.
    J Autoimmun. 2021;119:102612.
    PubMed     Abstract available


  80. BERGLIN E, Mohammad AJ, Dahlqvist J, Johansson L, et al
    Anti-neutrophil cytoplasmic antibodies predate symptom onset of ANCA-associated vasculitis. A case-control study.
    J Autoimmun. 2021;117:102579.
    PubMed     Abstract available


  81. GARIMELLA MG, He C, Chen G, Li QZ, et al
    The B cell response to both protein and nucleic acid antigens displayed on apoptotic cells are dependent on endosomal pattern recognition receptors.
    J Autoimmun. 2021;117:102582.
    PubMed     Abstract available


    January 2021
  82. MOLDOVEANU Z, Suzuki H, Reily C, Satake K, et al
    Experimental evidence of pathogenic role of IgG autoantibodies in IgA nephropathy.
    J Autoimmun. 2021;118:102593.
    PubMed     Abstract available


  83. PENG B, Temple BR, Yang J, Geng S, et al
    Identification of a primary antigenic target of epitope spreading in endemic pemphigus foliaceus.
    J Autoimmun. 2021;116:102561.
    PubMed     Abstract available


    December 2020
  84. BUITRAGO-MOLINA LE, Pietrek J, Noyan F, Schlue J, et al
    Treg-specific IL-2 therapy can reestablish intrahepatic immune regulation in autoimmune hepatitis.
    J Autoimmun. 2020;117:102591.
    PubMed     Abstract available


  85. NOVELLI L, Motta F, De Santis M, Ansari AA, et al
    The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 - A systematic review of the literature.
    J Autoimmun. 2020;117:102592.
    PubMed     Abstract available


    November 2020
  86. SARMIENTO-MONROY JC, Espinosa G, Londono MC, Meira F, et al
    A multidisciplinary registry of patients with autoimmune and immune-mediated diseases with symptomatic COVID-19 from a single center.
    J Autoimmun. 2020;117:102580.
    PubMed     Abstract available


  87. ALBORZIAN DEH SHEIKH A, Gomaa S, Li X, Routledge M, et al
    A Guillain-Barre syndrome-associated SIGLEC10 rare variant impairs its recognition of gangliosides.
    J Autoimmun. 2020 Nov 19:102571. doi: 10.1016/j.jaut.2020.102571.
    PubMed     Abstract available


    September 2020
  88. GORABI AM, Hajighasemi S, Kiaie N, Gheibi Hayat SM, et al
    Corrigendum to "The pivotal role of CD69 in autoimmunity" [J. Autoimmun. 111C (2020) 102453].
    J Autoimmun. 2020 Sep 30:102548. doi: 10.1016/j.jaut.2020.102548.
    PubMed    


  89. GOKHALE AS, Gangaplara A, Lopez-Occasio M, Thornton AM, et al
    Corrigendum to "Selective deletion of Eos (Ikzf4) in T-regulatory cells leads to loss of suppressive function and development of systemic autoimmunity" [J. Autoimmun. 105C (2019) 102300].
    J Autoimmun. 2020 Sep 24:102544. doi: 10.1016/j.jaut.2020.102544.
    PubMed    


  90. CALABRESE LH, Caporali R, Blank CU, Kirk AD, et al
    Modulating the wayward T cell: New horizons with immune checkpoint inhibitor treatments in autoimmunity, transplant, and cancer.
    J Autoimmun. 2020 Sep 23:102546. doi: 10.1016/j.jaut.2020.102546.
    PubMed     Abstract available


  91. LOMBARDI A, Concepcion E, Hou H, Arib H, et al
    Retro-inverso D-peptides as a novel targeted immunotherapy for Type 1 diabetes.
    J Autoimmun. 2020 Sep 17:102543. doi: 10.1016/j.jaut.2020.102543.
    PubMed     Abstract available


  92. ZHAO Y, Wei W, Liu ML
    Extracellular vesicles and lupus nephritis - New insights into pathophysiology and clinical implications.
    J Autoimmun. 2020 Sep 4:102540. doi: 10.1016/j.jaut.2020.102540.
    PubMed     Abstract available


    August 2020
  93. GORABI AM, Kiaie N, Aslani S, Jamialahmadi T, et al
    Prospects for the potential of RNA interference in the treatment of autoimmune diseases: Small interfering RNAs in the spotlight.
    J Autoimmun. 2020 Aug 8:102529. doi: 10.1016/j.jaut.2020.102529.
    PubMed     Abstract available


    July 2020
  94. PATSOURAS M, Tsiki E, Karagianni P, Vlachoyiannopoulos PG, et al
    The role of thrombospondin-1 in the pathogenesis of antiphospholipid syndrome.
    J Autoimmun. 2020 Jul 21:102527. doi: 10.1016/j.jaut.2020.102527.
    PubMed     Abstract available


  95. MARZIALE A, Bettacchioli E, Picart G, Nafai S, et al
    Antiphospholipid autoantibody detection is important in all patients with systemic autoimmune diseases.
    J Autoimmun. 2020 Jul 18:102524. doi: 10.1016/j.jaut.2020.102524.
    PubMed     Abstract available


  96. LIU Y, Wang J, Luo S, Zhan Y, et al
    The roles of PPARgamma and its agonists in autoimmune diseases: A comprehensive review.
    J Autoimmun. 2020 Jul 1:102510. doi: 10.1016/j.jaut.2020.102510.
    PubMed     Abstract available


    June 2020
  97. THOME R, Casella G, Lotfi N, Ishikawa LWL, et al
    Primaquine elicits Foxp3(+) regulatory T cells with a superior ability to limit CNS autoimmune inflammation.
    J Autoimmun. 2020 Jun 25:102505. doi: 10.1016/j.jaut.2020.102505.
    PubMed     Abstract available


  98. BING SJ, Silver PB, Jittayasothorn Y, Mattapallil MJ, et al
    Autoimmunity to neuroretina in the concurrent absence of IFN-gamma and IL-17A is mediated by a GM-CSF-driven eosinophilic inflammation.
    J Autoimmun. 2020 Jun 24:102507. doi: 10.1016/j.jaut.2020.102507.
    PubMed     Abstract available


  99. THAM EL, Freeley SJ, Bearder S, Barros FF, et al
    VISTA deficiency protects from immune complex-mediated glomerulonephritis by inhibiting neutrophil activation.
    J Autoimmun. 2020 Jun 22:102501. doi: 10.1016/j.jaut.2020.102501.
    PubMed     Abstract available


  100. HU S, Liu X, Li T, Li Z, et al
    LAG3 (CD223) and autoimmunity: Emerging evidence.
    J Autoimmun. 2020 Jun 20:102504. doi: 10.1016/j.jaut.2020.102504.
    PubMed     Abstract available


  101. DANG J, Xu Z, Xu A, Liu Y, et al
    Human gingiva-derived mesenchymal stem cells are therapeutic in lupus nephritis through targeting of CD39(-)CD73 signaling pathway.
    J Autoimmun. 2020 Jun 18:102491. doi: 10.1016/j.jaut.2020.102491.
    PubMed     Abstract available


  102. EFRAIM Y, Chen FYT, Stashko C, Cheong KN, et al
    Alterations in corneal biomechanics underlie early stages of autoimmune-mediated dry eye disease.
    J Autoimmun. 2020 Jun 18:102500. doi: 10.1016/j.jaut.2020.102500.
    PubMed     Abstract available


  103. RODRIGUEZ Y, Novelli L, Rojas M, De Santis M, et al
    Autoinflammatory and autoimmune conditions at the crossroad of COVID-19.
    J Autoimmun. 2020 Jun 16:102506. doi: 10.1016/j.jaut.2020.102506.
    PubMed     Abstract available


  104. ZHOU X, Kailemia MJ, Sun Y, Shuai Z, et al
    Glycomic analysis of antibody indicates distinctive glycosylation profile in patients with autoimmune cholangitis.
    J Autoimmun. 2020 Jun 13:102503. doi: 10.1016/j.jaut.2020.102503.
    PubMed     Abstract available


  105. ZEN M, Fuzzi E, Astorri D, Saccon F, et al
    SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: A cross-sectional study on 916 patients.
    J Autoimmun. 2020 Jun 8:102502. doi: 10.1016/j.jaut.2020.102502.
    PubMed     Abstract available


  106. WONG HY, Schwarz H
    CD137 / CD137 ligand signalling regulates the immune balance: A potential target for novel immunotherapy of autoimmune diseases.
    J Autoimmun. 2020 Jun 4:102499. doi: 10.1016/j.jaut.2020.102499.
    PubMed     Abstract available


  107. WONG ASL, Gruber DR, Richards AL, Sheldon K, et al
    Tolerization of recent thymic emigrants is required to prevent RBC-specific autoimmunity.
    J Autoimmun. 2020 Jun 2:102489. doi: 10.1016/j.jaut.2020.102489.
    PubMed     Abstract available


    May 2020
  108. KOMICI K, Faris P, Negri S, Rosti V, et al
    Systemic lupus erythematosus, endothelial progenitor cells and intracellular Ca(2+) signaling: A novel approach for an old disease.
    J Autoimmun. 2020 May 29:102486. doi: 10.1016/j.jaut.2020.102486.
    PubMed     Abstract available


  109. COLASANTI T, Sabatinelli D, Mancone C, Giorgi A, et al
    Homocysteinylated alpha 1 antitrypsin as an antigenic target of autoantibodies in seronegative rheumatoid arthritis patients.
    J Autoimmun. 2020 May 27:102470. doi: 10.1016/j.jaut.2020.102470.
    PubMed     Abstract available


  110. DE BONT CM, Stokman MEM, Faas P, Thurlings RM, et al
    Autoantibodies to neutrophil extracellular traps represent a potential serological biomarker in rheumatoid arthritis.
    J Autoimmun. 2020 May 22:102484. doi: 10.1016/j.jaut.2020.102484.
    PubMed     Abstract available


  111. YANG Y, Peng F, Wang R, Yang M, et al
    Corrigendum to "The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China" [J. Autoimmun. 109C (2020) 102434].
    J Autoimmun. 2020 May 15:102487. doi: 10.1016/j.jaut.2020.102487.
    PubMed    


  112. CARL PL, Fried HM, Cohen PL
    Proteins in assemblages formed by phase separation possess properties that promote their transformation to autoantigens: Implications for autoimmunity.
    J Autoimmun. 2020 May 11:102471. doi: 10.1016/j.jaut.2020.102471.
    PubMed     Abstract available


    April 2020
  113. ZHANG D, Kinloch AJ, Srinath A, Shenkar R, et al
    Antibodies in cerebral cavernous malformations react with cytoskeleton autoantigens in the lesional milieu.
    J Autoimmun. 2020 Apr 30:102469. doi: 10.1016/j.jaut.2020.102469.
    PubMed     Abstract available


  114. LONG D, Chen Y, Wu H, Zhao M, et al
    Corrigendum to "Clinical Significance and Immunobiology of IL-21 in Autoimmunity"[J. Autoimmun. 99C (2019) p1-14].
    J Autoimmun. 2020 Apr 28:102455. doi: 10.1016/j.jaut.2020.102455.
    PubMed    


  115. ZHANG X, Olsen N, Zheng SG
    The progress and prospect of regulatory T cells in autoimmune diseases.
    J Autoimmun. 2020 Apr 15:102461. doi: 10.1016/j.jaut.2020.102461.
    PubMed     Abstract available


  116. GORABI AM, Hajighasemi S, Kiaie N, Gheibi Hayat SM, et al
    The pivotal role of CD69 in autoimmunity.
    J Autoimmun. 2020 Apr 11:102453. doi: 10.1016/j.jaut.2020.102453.
    PubMed     Abstract available


  117. LEVITE M, Zelig D, Friedman A, Ilouz N, et al
    Dual-Targeted Autoimmune Sword in Fatal Epilepsy: Patient's glutamate receptor AMPA GluR3B peptide autoimmune antibodies bind, induce Reactive Oxygen Species (ROS) in, and kill both human neural cells and T cells.
    J Autoimmun. 2020 Apr 10:102462. doi: 10.1016/j.jaut.2020.102462.
    PubMed     Abstract available


  118. GATTO M, Radu CM, Luisetto R, Ghirardello A, et al
    Immunization with Pentraxin3 prevents transition from subclinical to clinical lupus nephritis in lupus-prone mice: Insights from renal ultrastructural findings.
    J Autoimmun. 2020 Apr 4:102443. doi: 10.1016/j.jaut.2020.102443.
    PubMed     Abstract available


    March 2020
  119. BAE HR, Leung PSC, Hodge DL, Fenimore JM, et al
    Multi-omics: Differential expression of IFN-gamma results in distinctive mechanistic features linking chronic inflammation, gut dysbiosis, and autoimmune diseases.
    J Autoimmun. 2020 Mar 24:102436. doi: 10.1016/j.jaut.2020.102436.
    PubMed     Abstract available


    December 2019
  120. SABOURI S, Benkahla MA, Kiosses WB, Rodriguez-Calvo T, et al
    Human herpesvirus-6 is present at higher levels in the pancreatic tissues of donors with type 1 diabetes.
    J Autoimmun. 2019 Dec 6:102378. doi: 10.1016/j.jaut.2019.102378.
    PubMed     Abstract available


    June 2019
  121. ZENTSOVA I, Parackova Z, Kayserova J, Palova-Jelinkova L, et al
    Monocytes contribute to DNA sensing through the TBK1 signaling pathway in type 1 diabetes patients.
    J Autoimmun. 2019 Jun 27. pii: S0896-8411(19)30191.
    PubMed     Abstract available


  122. TENSPOLDE M, Zimmermann K, Weber LC, Hapke M, et al
    Regulatory T cells engineered with a novel insulin-specific chimeric antigen receptor as a candidate immunotherapy for type 1 diabetes.
    J Autoimmun. 2019 Jun 5. pii: S0896-8411(19)30165.
    PubMed     Abstract available


    November 2018
  123. POSTIGO-FERNANDEZ J, Creusot RJ
    A multi-epitope DNA vaccine enables a broad engagement of diabetogenic T cells for tolerance in Type 1 diabetes.
    J Autoimmun. 2018 Nov 17. pii: S0896-8411(18)30523.
    PubMed     Abstract available


    October 2018
  124. ALPER CA, Larsen CE, Trautwein MR, Alford DR, et al
    A stochastic epigenetic Mendelian oligogenic disease model for type 1 diabetes.
    J Autoimmun. 2018 Oct 8. pii: S0896-8411(18)30427.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: